drugset / Trial / NCT07295054

3 mL Inhaled Methoxyflurane for Intrauterine Device (IUD) Insertion

NCT07295054

Phase 4 Recruiting 110 enrolled Women's College Hospital
RandomizedParallel-groupTriple-blindTreatment

Summary

Intrauterine device (IUD) insertion is a common contraceptive procedure often associated with moderate to severe pain, particularly among nulliparous individuals. Current pain management strategies, such as over-the-counter analgesics, are frequently inadequate. Methoxyflurane, a short-acting, self-administered inhaled analgesic, has been shown to provide rapid and effective pain relief in acute and procedural settings. This study aims to evaluate whether 3 mL of inhaled Methoxyflurane (via Penthrox inhaler) improves patient satisfaction by reducing pain and anxiety during IUD insertion.

Timeline

Start
2026-04-27
Primary completion
2026-12
Completion
2027-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Methoxyflurane Small molecule 3 ml Inhaled

Indications

No indication recorded.